5:1 Reverse Stock Split Decision for Price Stabilization


  • 5:1 reverse stock split (5 shares consolidated into 1, par value from 100 won to 500 won)
  • Total shares reduced from 77,549,006 to 15,509,801 (no capital reduction)
  • Purpose: stabilize stock price and enhance corporate value
  • Schedule: shareholder meeting 2026-07-06, effective 2026-07-22, trading halt 2026-07-20~08-10, new shares listing 2026-08-11
  • Fractional shares to be paid in cash based on closing price on listing day
  • Subject to shareholder approval at special meeting; details may change
ADVERTISEMENT (250px+)

KOSDAQ Filing Information


  • Filing: Stock Merger Decision
  • Company: GL Pharm Tech (204840)
  • Submission: GL Pharm Tech Corp.
  • Receipt: 05-19-2026
  • Under KRX KOSDAQ Market Division